Documents

31.pdf

Description
Longitudinal Observations of a Large, Collaborative Insulin Pump Therapy Program for Children in Kazakhstan Gulmira Abduakhassova1, Akmaral Nurbekova2, Aigul Muratalina3, Meng Mao4, John B. Welsh4, Larisa Yedigarova4, Francine R. Kaufman4 1. 2. 3. 4. Medical University Astana, Department of Endocrinology, Astana, Kazakhstan Kazakh National Medical University, Department of Endocrinology, Almaty, Kazakhstan Medtronic, Inc., Astana, Kazakhstan Medtronic, Inc.,, Northridge, United States Presenta
Categories
Published
of 13
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Related Documents
Share
Transcript
  Gulmira Abduakhassova 1 , Akmaral Nurbekova 2 , Aigul Muratalina 3 , Meng Mao 4 , John B. Welsh 4 , Larisa Yedigarova 4 , Francine R. Kaufman 4 Longitudinal Observations of a Large, Collaborative Insulin Pump Therapy Program for Children in Kazakhstan   Presentation O20 Oral Session III: Diabetes Projects in Developing Countries September 3, 2014, 15:00-16:30 1.Medical University Astana, Department of Endocrinology, Astana, Kazakhstan 2.Kazakh National Medical University, Department of Endocrinology, Almaty, Kazakhstan 3.Medtronic, Inc., Astana, Kazakhstan 4.Medtronic, Inc.,, Northridge, United States    Drs. Abduakhassova and Nurbekova have received research support from Medtronic, Inc. Drs. Mao, Welsh, Yedigarova, and Kaufman are employees of Medtronic, Inc.   Disclosures    Kazakhstan Russia Number of T1DM Children (5-15 y/o) ~1000 27, 000 Number of T1DM Children on Insulin Pump Therapy Prior to Kazakh Program Limited to a Handful >1900 Insulin Coverage 100% Government 100% Government* Pump & Consumables Coverage No Available Program ã Federal ã Regional ã Charity* Only a few post-Soviet countries, like Russia and Kazakhstan, have full state coverage for insulin distribution to children with T1DM Background    Project Baiterek  –  Insulin Pump Therapy for Children with T1D in Kazakhstan   Objectives: ã To develop a partnership between the Kazakhstan Ministry of Health, Industry (Medtronic), and the Diabetes Association of the Republic of Kazakhstan to advance diabetes therapy for children with T1D ã To give access to insulin pumps for 790 patients, ages 5  –  15 years of age, with patients starting within 1 year ã To develop a program to evaluate outcomes
Search
Tags
Related Search
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks